| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |